United States · 
Who invested in Cyclerion Therapeutics?
Cyclerion Therapeutics's investors include Polaris Partners and Invus.
United States · Funded startup
Who invested in Cyclerion Therapeutics
Funding summaryUpdated 26 Oct 2026
$5.0Mraised across 1 round since 2023, from 1 source
- Latest round
- Round, $5.0MMay 2023
- Investors
- 2
The rounds
- May 2023
Founders and team
From Cyclerion Therapeutics's own website and the SEC filings it signed: 12 on the team.
- Jonathan ViolinChief Executive Officer
- Gan WeiChief Technology Officer
- Mark VignolaChief Financial Officer
- Matthew LeoniChief Medical Officer
- Andrew GottesdienerDirector
- Heidi HensonDirector
- Michelle PerniceDirector
- Nimish ShahDirector
- Tomas KiselakChairman
- Anjeza M. GjinoExecutive Officeri
- Cheryl M. GaultExecutive Officeri
- Peter M. HechtDirector, Executive Officeri
On the board, as filediErrol M. De SouzaOle M. IsacsonSteven M. HymanTerrance M. McGuire
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Cyclerion Therapeutics
How much has Cyclerion Therapeutics raised?
Cyclerion Therapeutics has raised $5.0M across 1 round since 2023.
When did Cyclerion Therapeutics last raise?
Cyclerion Therapeutics's most recent round was an Undisclosed round of $5.0M in May 2023.
What was Cyclerion Therapeutics's biggest round?
Its most recent round, $5.0M in May 2023, is also its largest on record.
Who backed Cyclerion Therapeutics first?
Cyclerion Therapeutics's first round on record, in May 2023, was backed by Polaris Partners and Invus.
What stage is Cyclerion Therapeutics at?
Cyclerion Therapeutics's latest named round is an Undisclosed round, in May 2023.
Where is Cyclerion Therapeutics based?
Cyclerion Therapeutics is based in the United States.
Companies like Cyclerion Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.